PAIN
Volume 130, Issue 1 , Pages 144-156 , July 2007

Development and validation of the Current Opioid Misuse Measure

  • Stephen F. Butler

      Affiliations

    • Inflexxion, Inc., Newton, MA 02464, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 603 673 1317; fax: +1 603 673 1317.
    • ,
  • Simon H. Budman

      Affiliations

    • Inflexxion, Inc., Newton, MA 02464, USA
    • ,
  • Kathrine C. Fernandez

      Affiliations

    • Inflexxion, Inc., Newton, MA 02464, USA
    • ,
  • Brian Houle

      Affiliations

    • Inflexxion, Inc., Newton, MA 02464, USA
    • ,
  • Christine Benoit

      Affiliations

    • Inflexxion, Inc., Newton, MA 02464, USA
    • ,
  • Nathaniel Katz

      Affiliations

    • Inflexxion, Inc., Newton, MA 02464, USA
    • Tufts University School of Medicine, Boston, MA 02111, USA
    • Analgesic Research, Newton, MA 02464, USA
    • ,
  • Robert N. Jamison

      Affiliations

    • Pain Management Center, Departments of Anesthesia and Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA

Received 16 August 2006 ,Revised 18 December 2006 ,Accepted 16 January 2007.

References 

  1. Adams LL, Gatchel RJ, Robinson RC, Polatin P, Gajraj N, Deschner M, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symp Manage. 2004;27:440–459
  2. Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006;32:287–293
  3. American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer pain (4th ed). Glenview, IL: American Pain Society, 1999.
  4. American Pain Society. Guideline for the management of pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis. Clinical practice guideline number 2. Glenview, IL: American Pain Society, 2002.
  5. Butler SF. The baby or the bath water?. Addiction. 2004;99:413–414
  6. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:65–75
  7. Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain. 1997;13:150–155
  8. Coambs RE, Jarry JL, Santhiapillai AC, Abrahamsohn RV, Atance CM. The SISAP: A new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain in general medical practice. Pain Res Manage. 1996;1:155–162
  9. Compton PJ, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and ‘problematic’ substance use: evaluation of a pilot assessment tool. J Pain Symp Manage. 1998;16:355–363
  10. Crowne DP, Marlowe D. The Approval Motive: Studies in Evaluative Dependence. New York, NY: Wiley; 1964;
  11. Friedman R, Li V, Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med. 2003;4:181–184
  12. General Accounting Office. Prescription Drugs: OxyContin Abuse and Diversion and Efforts to Address the Problem. Available at: http://www.gao.gov/new.items/d04110.pdf. December, 2003.
  13. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Sym Manage. 2004;28:176–188
  14. Hampton T. Physicians advised on how to offer pain relief while preventing opioid abuse. JAMA. 2004;292:1164–1166
  15. Jackson KM, Trochim WMK. Concept mapping as an alternative approach for the analysis of open-ended survey responses. Organiz Res Method. 2002;5:307–336
  16. Joranson DE, Ryan KM, Aaron M, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283:1710–1714
  17. Kirsh KL, Whitcomb LA, Donaghy D, Passik SD. Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain. 2002;18(Suppl):S52–S60
  18. Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, et al. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Sym Manage. 2004;28:250–258
  19. Michna E, Jamison RN, Pham LD, Ross EL, Janfaza D, Nedeljkovic SS, et al. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain. 2007;23:173–179
  20. National Institutes of Health (NIH). Prescription opioid use and abuse in the treatment of pain. RFA-DA-06-005. Available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-06-005.html. Accessed on 1/18/2007.
  21. Nedeljkovic SS, Wasan AD, Jamison RN. Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain. 2002;18(Suppl):S39–S51
  22. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed.. New York: McGraw-Hill; 1994;
  23. Obuchowski N, McClish D. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Statistics Med. 1997;16:1529–1542
  24. Passik SD, Kirsh KL. The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. Pain Med. 2003;4:186–189
  25. Passik SD, Kirsh KL, Whitcomb L, Portenoy RK, Katz NP, Kleinman L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26:552–561
  26. Reynolds WM. Development of reliable and valid short forms of the Marlowe–Crowne Social Desirability Scale. J Clin Psychol. 1982;38:119–125
  27. Robinson RC, Gatchel RJ, Polatin P, Deschner M, Noe C, Gajraj N. Screening for problematic prescription opioid use. Clin J Pain. 2001;17:220–228
  28. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed.. Boston, MA: Little, Brown & Co; 1991;
  29. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18:S28–S38
  30. Stewart AL, Hayes RD, Ware JE. Methods of constructing health measures. In:  Stewart AL,  Ware JE editor. Measuring Functioning and Well-being. Durham, NC: Duke University Press; 1993;
  31. Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Person Assess. 2003;80:99–103
  32. Streiner DL. Being inconsistent about consistency: when coefficient alpha does and doesn’t matter. J Person Assess. 2003;80:217–222
  33. Trochim WMK. An introduction to concept mapping. Eval Prog Planning. 1989;12:1–16
  34. Trochim WMK. The reliability of concept mapping. Paper presented at the Annual Meeting of the American Evaluation Association, Dallas, 1993.
  35. Trochim WMK, Cook JA, Setz RJ. Concept mapping to develop a conceptual framework of staff’s views of a supported employment program for persons with severe mental illness. J Consult Clin Psychol. 1994;62:766–777
  36. Walter SD, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Statistics Med. 1998;17:101–110
  37. Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Psychiatric history and psychological adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. (in press).
  38. Winer BJ. Statistical Principles in Experimental Design. 3rd ed.. New York: McGraw-Hill; 1991;

PII: S0304-3959(07)00022-X

doi: 10.1016/j.pain.2007.01.014

PAIN
Volume 130, Issue 1 , Pages 144-156 , July 2007

Article Tools

* Image Usage & Resolution